• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • University of California Granted Two New U.S. CRISPR-Cas9 Patents americanpharmaceuticalreview
    July 24, 2019
    The U.S. Patent and Trademark Office (USPTO) has awarded two new patents to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of the CRISPR-Cas9 gene-editing technology.
  • Volition Granted Four Additional Patents prnasia
    September 15, 2017
    Dr. Jake Micallef, Chief Scientific Officer of Volition, commented, "Our worldwide portfolio of granted patents that protects various aspects of Volition's Nu.QTM technology is growing.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service